Langsung ke konten utama
nferen1104 Am J Psychiatry 159:7, July 2002

Clinical Case Conference
A Case of “Pfropfschizophrenia”:
Kraepelin’s Bridge Between Neurodegenerative
and Neurodevelopmental Conceptions of Schizophrenia

Avram H. Mack, M.D.
James J. Feldman, M.D., M.P.H.
Ming T. Tsuang, M.D., Ph.D., D.Sc.


The notion that schizophrenia, as conceived by Kraepelin,is a neurodegenerative disorder has been challenged by new research on the nature of the cognitive impairment in this disease; instead, schizophrenia is increasingly described as a neurodevelopmental disorder (1). For Kraepelin, the unifying observation among the catatonic, hebephrenic, and paranoid types of dementia praecox was a continued decline of intellectual function. However, empirical findings have demonstrated that cognitive function does not universally decline in patients with schizophrenia. Some authors have suggested that low intellectual functioning is a premorbid and fixed feature (2). Others have sought to separate patients according to different “trajectories” of lifetime intellectual function that include subsets of schizophrenic patients with intellectual functioning that was either compromised from a very early age or preserved at normal premorbid levels (3, 4). Finally, there have been attempts to determine if there are differences in change among cognitive functions (intellect, memory, executive, and attention) in schizophrenia (3). These data seem to be mutually exclusive of some of Kraepelin’s most important observations, and they generally support the “static encephalopathy” concept that asserts that schizophrenia is due to a stable neurodevelopmental brain lesion (5). The increasing dominance of the neurodevelopmental paradigm is illustrated by the American Academy of Child and Adolescent Psychiatry’s declaration that “schizophrenia is a neurodevelopmental disorder” (6) and also by Prusiner’s exclusion of schizophrenia (7) from the neurodegenerative disorders, all of which, in his perspective, “result from abnormalities in the processing of proteins.” One wonders whether this dichotomous landscape has room for only one perspective at a time. Download

Komentar

Postingan populer dari blog ini

You Can Hypnotize Everyone With Simple Way.

You Can Hypnotize Everyone With Simple Way The Five Stage to Hypnotize Others Went you want to hypnotize some one, you have to learn how to hypnotize someone in ten minutes. I will show you how to using the simple hypnotize method. The key word of this method are: Do the instruction with pretty straight-forward and do bear in mind that not everyone is susceptible to hypnosis. Here is the five instantly step for hypnotize others in ten minutes 1. Make it conducive Dim the lights, make sure there are no distracting noises, light a few scented candles. 2. Tell your subject to relax Aside from relaxing his or her mind and body, ask your subject to slowly breathe in through the nose and out through the mouth. 3. Have him or her expel all thoughts, worries, concerns Tell your subject to add colors to each breath and assign a thought, worry or concern to that colored breath, and expel it as he or she breathes out. 4. Have the subject fill up the space created with an ima...

Interview Form Templates

Alzheimer’s Disease

Alzheimer’s  Disease Introduction A permanent disease that can’t be change, Alzheimer’s disease is a progressive condition in which nerve cells in the brain degenerate, In the period of this disease, the brain size will be decreases . Alzheimer’s disease is the most common degenerative brain disorder. In US, approximately 4 million Americans are afflicted with Alzheimer’s disease and the sufferer  number predicted grow to 14 million by 2050. Although research funded that onset of the disease is rare before the age of 60. After that age, the incidence of Alzheimer’s disease increases steadily, and more than one-quarter of all individuals above the age of 85 have this disease. In addition, Alzheimer’s disease is the cause of about three-quarters of all cases of dementia in individuals above the age of 65. On average, most individuals survive for 8 to 10 years after being diagnosed with Alzheimer’s disease and will spend five of those y...